| Hygieia

Who is Hygieia?

Hygieia was founded in 2008 out of the University of Michigan because we believe there is a better way to use insulin.

Over 20,000 patient-years of data support insulin therapy as an effective treatment for both type 1 and type 2 diabetes. Yet only a fraction of those taking insulin reach the American Diabetes Association (ADA) or European Association for the Study of Diabetes (EASD) recommended A1C goal. Why do so many of those who take insulin struggle? In study after study, when expert teams continually worked to fine-tune insulin therapy, patients reached their A1C targets. But self-adjusting insulin treatment plans proved too difficult for people to do without the weekly support of their healthcare teams.

If there were an easy way for someone taking insulin to get weekly treatment updates, would it help them succeed? The extensive research conducted to answer this question said yes. And so, Hygieia was founded. Hygieia’s founders, Drs. Eran Bashan and Israel Hodish named their company after a goddess from Greek and Roman mythology. Hygieia was the daughter of the “god of medicine” – Asclepius. She was known for disease prevention and good health. 

Statue of goddess Hygieia
Image from Howard Cheng

What is the d-Nav® Program?

The d-Nav® Program was created to improve and simplify insulin treatment to make a difference and help more people who are on insulin therapy succeed. The d-Nav® program uses an FDA-cleared app to identify glucose patterns and automatically recommend an insulin dose each time the patient injects.

The d is for “diabetes” and Nav is for “navigate”. d-Nav® is a navigation tool for successful insulin therapy. Ever used a GPS to find your way? We wanted to create a similar experience for insulin therapy. We know the road gets tricky and that occasionally we take a wrong turn. d-Nav® is there to help. 

At Hygieia, we are cheering for your success and good health. We hope you find your way to make diabetes a smaller part of your life!

Find out more about our people.